PCVX Form 144: Insider sales of 11,895 shares

PCVX filed a Form 144 reporting proposed and recent dispositions of Common Stock by a holder.

Rhea-AI Filing Summary

PCVX filed a Form 144 reporting proposed and recent dispositions of Common Stock by a holder. The filing lists RSU vesting events dated 08/31/2025 and 09/02/2025, and discloses three sales by James Wassil of 7,395, 2,250 and 2,250 shares on 03/10/2026, 04/01/2026 and 05/01/2026 respectively, with dollar values shown for each disposition.

Insights

Securities Compliance Analyst

Regulation 144 notice of proposed/resolved sales; routine disclosure of dispositions and vesting.

This Form 144 lists vesting events (RSUs) and recent open-market or broker transactions by a single holder, including specific share counts and proceeds. The filing functions as a compliance disclosure under resale rules.

Cash‑flow treatment is the holder's proceeds; the filing does not state issuer proceeds or other parties. Subsequent filings may report additional sales or updated compliance statements.

Equity Markets Associate

Transactions are documented with dates, share counts, and gross proceeds — useful for trade-level transparency.

The record shows three dispositions by James Wassil totaling 11,895 shares across March–May 2026 with per‑trade dollar amounts provided. RSU vesting entries are listed earlier and may explain sources of sold shares.

This filing itself is administrative; market impact depends on additional trades and context not shown here.

Key Figures

Sale — 03/10/2026: 7,395 shares Proceeds — 03/10/2026: $435,438.31 Sale — 04/01/2026: 2,250 shares +4 more

7 metrics

Sale — 03/10/2026 7,395 shares sale date <date>03/10/2026</date>

Proceeds — 03/10/2026 $435,438.31 gross proceeds reported for <date>03/10/2026</date>

Sale — 04/01/2026 2,250 shares sale date <date>04/01/2026</date>

Proceeds — 04/01/2026 $131,475.60 gross proceeds reported for <date>04/01/2026</date>

Sale — 05/01/2026 2,250 shares sale date <date>05/01/2026</date>

Proceeds — 05/01/2026 $127,870.65 gross proceeds reported for <date>05/01/2026</date>

RSU vesting examples 1,538 shares; 660 shares; 52 shares vesting dates <date>08/31/2025</date> and <date>09/02/2025</date>

Key Terms

Form 144, RSU Vest, Regulation 144, Proceeds

4 terms

Form 144 regulatory

"144: Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

RSU Vest financial

"08/31/2025 | RSU Vest | Issuer"

Regulation 144 regulatory

"144: Securities To Be Sold"

Proceeds financial

"7395 | 435438.31"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does PCVX Form 144 disclose about insider sales?

The Form 144 discloses three sales by James Wassil: 7,395, 2,250, and 2,250 shares on 03/10/2026, 04/01/2026, and 05/01/2026, with gross dollar amounts shown for each trade.

Do the filings show any RSU vesting for PCVX?

Yes. The filing lists RSU vest events dated 08/31/2025 and 09/02/2025, with vesting quantities such as 52, 1,538, and 660 shares recorded in the excerpt.

Who received proceeds from the reported sales in PCVX Form 144?

The proceeds are reported alongside each disposition by James Wassil, indicating the holder received the gross amounts; the filing does not state any proceeds were received by the issuer.

Does the Form 144 indicate the sales were voluntary or required for compliance?

The filing documents proposed or completed dispositions under Regulation 144 rules but does not characterize them as voluntary or mandatory; it provides dates, share counts, and dollar amounts without further explanation.

How many shares were sold by James Wassil in total as shown?

The three reported dispositions by James Wassil total 11,895 shares (7,395 + 2,250 + 2,250) across 03/10/2026 to 05/01/2026 according to the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/01/2026 - 04:26 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001813798
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Vaxcyte, Inc.
SEC File Number	001-39323
Address of Issuer	825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CALIFORNIA 94070
Phone	650-837-0111
Name of Person for Whose Account the Securities are To Be Sold	Wassil Jim
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. 11 Madison Ave 4th Floor New York NY 10010	2250	114772.50	144397682	06/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/31/2025	RSU Vest	Issuer			52	08/31/2025	NA
Common	09/02/2025	RSU Vest	Issuer			1538	09/02/2025	N/A
Common	09/02/2025	RSU Vest	Issuer			660	09/02/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
James Wassil 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070	Common	03/10/2026	7395	435438.31
James Wassil 825 INDUSTRIAL ROAD STE. 300 SAN CARLOS CA 94070	Common	04/01/2026	2250	131475.60
James Wassil 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070	Common	05/01/2026	2250	127870.65

144: Remarks and Signature

Remarks
Date of Notice	06/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/09/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for James Wassil
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)